Alzheimer

TORONTO, 20 juill. 2023 (GLOBE NEWSWIRE) -- La Société Alzheimer du Canada en collaboration avec la Fondation Brain Canada, les Instituts de recherche en santé du Canada — Institut du…

Whether enjoyed on its own or mixed into a latte, Americano or even a martini, espresso provides an ultra-concentrated jolt of caffeine to coffee lovers. But it might do more than just wake…

Lewy body disease is the second most common neurodegenerative disease after Alzheimer's disease. A research group from Lund University has now shown that the disease can be detected before…

With yet a third new Alzheimer's drug expected to be approved by the Food and Drug Administration (FDA), the field is beginning to show progress in the fight to slow the disease. But the…

TORONTO, 17 juill. 2023 (GLOBE NEWSWIRE) -- La Société Alzheimer de l’Ontario exprime son optimisme à l’occasion de la publication, aujourd’hui, des données complètes des essais cliniques…

A recent study from the lab of the University of Kentucky's Sanders-Brown Center on Aging Director Linda Van Eldik, Ph.D., has been published in PLOS ONE. The work centers around the idea…

TORONTO, July 17, 2023 (GLOBE NEWSWIRE) -- The Alzheimer Society of Ontario is expressing its optimism at today’s release of full clinical trial data from the phase three trial of…

They are seen as a beacon of hope for energy-saving electronics and the high-tech of the future: topological quantum materials. One of their properties is the conduction of spin-polarized…

Two pathologies drive the progression of Alzheimer's disease. Early on, amyloid beta plaques lead the way, but around the time cognitive symptoms arise, tau tangles take over as the driving…

By MATTHEW PERRONE - AP Health Writer WASHINGTON (AP) — U.S. officials granted full approval to a closely watched Alzheimer’s drug on Thursday,…